d, L-3-Hydroxy-4-methylkynurenine was prepared from 3-methoxy-4-methylanthranilic acid and found to be a competitive precursor with L-tryptophan in the biosynthesis of actinomycin D by Streptomyces antibioticus (ATCC14888).
Treatment of the product (II) with thionylchloride gave the acid chloride (III) which was then reacted with ethoxymagnesium-malonic ester. After hydrolysis to the ketone (IV), the product was brominated (in acetic acid) to give a monobromoketone (V). This was condensed with acetaminomalonic ester and sodium hydride (in dimethylformamide) and the product was hydrolyzed and reduced with HI and red phosphorus to give 3-hydroxy-4-methylkynurenine (VI).
The second approach ( Fig. 3 ) started with the nitroketone (IV of Fig. 2 ) which upon reaction with diethyloxalate and sodium ethoxide gave the pyruvic ester (VII). The oxime (VIII) was then hydrolyzed and reduced with HI and red phosphorus (as mentioned in the previous synthesis) to give 2-Nitro-3-methoxy-4-methylbenzoyl chloride (III) : A solution of 8.0 g of 2-nitro-3-methoxy-4-methylbenzoic acid (prepared by Simonsen's method 3) in 80 ml of CHC13was boiled with stirring with 9.0ml of thionylchloride for 1 hour. The excess thionylchloride and CHC13were removed by evaporation under reduced pressure and the resultant acid chloride was used immediately in the preparation of 2-nitro-3-methoxy-4-methylacetophenone (IV). 2-Nitro-3-methoxy-4-methylacetophenone (IV) : 0.1 ml of CC14 and 1.0ml of abs. EtOH were added to 1.0g of magnesium turnings (maintained under anhydrous conditions). As soon as the reaction had begun, 30ml of abs. ethylether was added with stirring. This was followed by a mixture of 6.5g of diethylmalonate, 4.0ml of abs. EtOH, and 5.0ml of abs. ethylether. This latter solution was added at such a rate that the rapid boiling was maintained, and when all had been added, the mixture was boiled under reflux for 3 hours until all of the magnesium had dissolved. The acid chloride (III) dissolved in 20ml of abs. ethylether was added to the above gray solution.
The reaction mixture was heated throughout the addition of the acid chloride until the dark red solution became too viscous to be stirred. After an additional 15 minutes of heating, the mixture was cooled and shaken with 50ml of 10% H2SO4 until all of the solids had dissolved. The ethylether phase was separated and the aqueous layer extracted with 25ml of ethylether. The combined ether extracts were washed with H2O, dried over MgSC>4,and concentrated. A mixture of 12ml of glacial acetic acid, 1.5ml of concentrated H2SO4, and 8ml ofH2O wasadded to the residue and the mixture heated under reflux for 4 hours. The solution was then cooled, made alkaline by addition of sufficient 20 %NaOHand then extracted with ethylether. The ether extract was washed with H2O, dried over MgSC>4, decolorized with charcoal, and concentrated to give 6.5 g of IV as a colorless oil. Although this material was pure enough to be used in the next step of the reaction sequence, it could be purified further by chromatography on Florisil with ethylether as eluant. 2-Bromo (2/-nitro-3/-methoxy-4/-methyl) acetophenone (V) : A solution of 3.0 g ofIV dissolved in 15ml of glacical acetic acid was mixed at room temperature with 2.2g of bromine dissolved in 15ml of glacial acetic acid. The solution was warmed to 55-60°C and stirred for 20minutes by which time the bromine color had completely disappeared. It was then stirred for an additional 10 minutes and poured into ice water. The white crystals were collected by filtration, washed with H2O, anddried in \acuo. A yield of 3.7g ofV was obtained (88 % yield) which had a melting point of 82-83°C. Recrystallization from EtOH gave a material which had m.p. 83-84°C in the form of white needles. Ethyl acetamino (2-nitro-3-methoxy-4-methylphenacyl) malonate : Diethylacetamidomalonate, 2.4g, was dissolved in 10ml of dry dimethylformamide. To this solution was added in small portions with stirring, 0.5g of a 57 % oil suspension of sodium hydride. The resulting suspension was stirred for an additional 15 minutes until all of the sodium hydride was dissolved. Then, 2.9 g of V dissolved in 10 ml of anhydrous dimethylformamide was added and the resulting dark brown solution stirred at room temperature for 16 hours. The dimethylformamide was then removed under reduced pressure at 40-50°C. The residue, a thick brown oil was used immediately for the next step of the sequence.
d, L-3-Hydroxy-4-methylkynurenine (VI) : The oil from 2.9 g of V was refluxed with stirring for 16 hours with 50ml of57 %HI and 0.8g of red phosphorus powder. The reactionmixturewas then diluted with 400ml of H2Oand filtered. The orange filtrate was further diluted with H2Oand passed through a Dowex50x12 resin column (200-400 mesh; H+ form; 5x30cm column). The column containing the absorbed reaction mixture was washed with 500ml of distilled H2Oand then with 2,000ml of 2.4n HC1. The 3-hydroxy-4-methyl-kynurenine (VI) was eluted with 4,000ml of 5n HC1. The 5n HC1 was removed by evaporation under reduced pressure. EtOH was added to the residue and the solution evaporated under reduced pressure thrice. Ethylether was then added and removed under reduced pressure. The cream colored powder was quickly collected by filtra- In 10ml of 60 %EtOH was dissolved 0.5g of the dihydrochloride and the solution adjusted to Ethyl (2-nitro-3-methoxy-4-methylbenzoyl) pyruvate (VII) : To a solution of 0.2g sodium in 10ml of abs. EtOH was added a mixture of 1.5g ofIV, 2.0ml ofdiethyloxalate, and 5.0ml ofabs. EtOH. This final solution first turned purple and then dark brown in color. It was kept for 16 hours at 0°C and then 15ml of 2n H2SO4and 10ml ofH2O wereadded. Thesolution wasthen extracted 3 times with 25ml portions of ethylether.
The combined ether extracts were dried (Na2SO4) and the solvent evaporated under reduced pressure. The resulting syrup crystallized.
These crystals (VII) were collected by filtration, washed with cold EtOH and dried (1.1 g, 40 %" yield). A sample was recrystallized from EtOHfor analytical purposes and had m.p. 80^81°C. Ethyl (2-nitro-3-methoxy-4-methylbenzoyl) pyruvate oxime (VIII) : To a solution of 0.7 g of pyruvic ester (VII) in 20ml of warm EtOH was added a solution of 0.5g hydroxylamine acetate in 20ml of hot EtOH. The mixture was kept at room temperature for 16 hours and then evaporated to dryness under reduced pressure. The colorless syrup was dissolved in a small amount of 9:l(v/v) mixture ofbeozene-EtOH and applied to a Florisil column. The oxime was eluted with more of the benzene-EtOH mixture. The eluate fractions were combined and evaporated under reduced pressure to yield 0.6 g of pure VIII as a colorless syrup. distilled water q.s. 1 liter. This chemically defined medium, 1,000 ml, were placed in a 2-liter cottonplugged Erlenmeyer flask and autoclaved at 121°C for 20 minutes. After cooling the flasks were inoculated with approximately 5 ml of a washed cell suspension of a 48-hour old culture ofS. antibioticus which had been grown on an NZ-AmineR-glucosetype mediumin shaken flasks at 30°C.
After 65 hours growth in the chemically defined medium (flasks placed on a rotary shaker at 30°C; Effect of Tryptophan Metabolites on the Incorporation of Tryptophan-14C into Actinomycin If 3-hydroxy-4-methylkynurenine is an intermediate in the biosynthesis of actinocin the addition of an excess of this compound to the washed cell suspension supplemented with labelled tryptophan would be expected to dilute the amount of radioactivity in the actinomycin. When3-hydroxy-4-methyl-kynurenine was added to the cell suspension, a significant reduction in the radioactivity was noted as shown in Table 1 . However, methylhydroxyanthranilic acid was even more effective and hydroxyanthranilic acid, hydroxykynurenine, and kynurenine were also active. If the concentrations of the competitive 3-hydroxy-4-methylkynurenine and methylanthranilic acid were increased there was some increase in effectiveness in dilution of radioactivity of the actinomycin, while the effectiveness of the hydroxyanthranilic acid as an antagonist was not significantly concentration dependent.
Effect of Tryptophan Metabolites on the Incorporation of L-Valine-14C into Actinomycin In order to determine whether the addition of the presumed D-tryptophan metabolites to the washed cell suspensions might affect total actinomycin synthesis the effect of these substances on incorporation of L-valine-14C was examined. As summarized in Table 2 we noted that in several instances the incorporation was increased by the addition of the tryptophan metabolites. in the actinomycin formed in the presence of L-valine-14C xyanthranilic acid was also effective. An experiment designed to test this hypothesis is summarized in Table 3 . While we noted that the The broken cells were centrifuged at 5,000 rpm for 15 minutes and the cell-free supernatant solution used for the enzymestudies. Thereaction mixture contained 0.5 //mole of 3-hydroxy-4-methylkynurenine, 50^g of pyridoxal phosphate and 0.5 ml of the crude enzyme, with a total volume of0.7ml. After 2-hour incubation at 30°C the reaction was stopped by addition of 0.05 ml of 2 n HC1. The 3-hydroxy-4-methylanthranilic acid was extracted with ethylacetate. After washing the extract with water, the ethylacetate was evaporated to dryness and the residue (after dissolving in a minimum of methanol) was spotted on the tic plate along with authentic 3-hydroxyanthranilic acid (obtained from Sigma Chemical Company). The chromatogram was developed using «-butanol-ethanol-water (2:1 : 1) system. Further study of the effect of increased incubation time on the formation of the hydroxymethylanthranilic acid showed that the rate decreased after 60-minute incubation. No significant conversion of 3-hydroxy-4-methylkynurenine to 3-hydroxy-4-methylanthranilic acid was obtained with a boiled enzyme preparation.
Discussion
Our studies show that addition of 3-hydroxy-4-methylkynurenine to actinomycin-forming cells of S. antibioticus suspended in radioactive tryptophan containing buffer resulted in reduction in the amount of radioactive tryptophan converted to actinomycin D while at the same time the amount of actinomycin synthesized was increased. These results suggest that the 3-hydroxy-4-methylkynurenine is an intermediate in the conversion of L-tryptophan to the actinocin portion of the molecule. We also noted an increase in actinomycin biosynthesis when 3-hydroxykynurenine and 3-hydroxyanthranilic acid were each added to the cell suspensions, and deduce from these observations that perhaps actinomycin synthesis may be limited by the rate of L-tryptophan conversion to the hydroxymethylanthranilic acid.
Since no 3-hydroxy-4-methylkynurenine could be isolated from actinomycin-producing cells, the essential role of this compoundas an intermediate in conversion of L-tryptophan to actinocin is not proved. On the other hand, the present studies do suggest that enzymes present in the actinomycin-forming S. antibioticus can convert the 3-hydroxy-4-methylanthranilic acid to actinomycin, and hopefully these enzymes are present for that purpose.
